Company intelligence / Profile preview

Qualitest Pharmaceuticals

Huntsville, Alabama, United Statesapax.com ↗

Ownership: Private
Employees: ~1100
Development stage: Commercial

Overview

Qualitest was the sixth largest U.S. generics company as measured by prescriptions filled, with a broad range of generic products encompassing 175 product families. Thirty-two of Qualitest's products were listed among the top 250 generics by total prescription volume[5][6].

Therapeutic areas: OtherNeurology
Modalities: Generic pharmaceuticalsControlled substancesLiquid formulations
Industry: Biotech

Drug pipeline

1 asset

Vasostrict

Commercial

Indications: Vasodilatory shock

Beyond the preview

Go deeper on Qualitest Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qualitest Pharmaceuticals.

Explore the full profile